Cover Image

Vaccination status (PCV13) of children with pneumococcal meningitis

Saved in:

Bibliographic Details
Main Authors:	Seidullayeva, Aliya (Author), Bayesheva, Dinagul (Author), Turdalina, Bayan (Author), Altynbekova, Alyona (Author), Omarova, Aliya (Author), Khamitova, Meruert (Author), Tashenov, Sabit (Author), Otarbayeva, Aislu (Author), Kozhakhmetov, Samat (Author)
Format:	Book
Published:	National Scientific Medical Center, 2020-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Measles at the present stage
by: Aygerim Zhuzzhasarova, et al.
Published: (2021)

Sensorineural hearing loss after bacterial meningitis in children
by: Aliya Seidullayeva, et al.
Published: (2017)

Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants
by: Johnna Perdrizet, et al.
Published: (2021)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
by: Helen L. Stacey, et al.
Published: (2019)

Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Maria L. Avila-Aguero, et al.
Published: (2017)

Response to: Pneumococcal conjugate vaccines in Latin America: are PCV10 and PCV13 similar in terms of protection against serotype 19A?
by: Javier Nieto Guevara, et al.
Published: (2018)

Response to article by Johnna Perdrizet et al.,"Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants"
by: Jorge A. Gómez, et al.
Published: (2022)

An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population
by: Ann-Charlotte Fridh, et al.
Published: (2024)

Adult non-invasive pneumococcal pneumonia in Portugal is dominated by serotype 3 and non-PCV13 serotypes 3-years after near universal PCV13 use in children
by: Catarina Silva-Costa, et al.
Published: (2023)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
by: Patricia Izurieta, et al.
Published: (2022)

Comparison of pneumococcal conjugate vaccine (PCV-13) cellular immune responses after primary and booster doses of vaccine
by: Timothy J. Chapman, et al.
Published: (2020)

The 13-valent pneumococcal conjugate vaccine (PCV13) does not appear to provide much protection on combined invasive disease due to the six PCV13 non-PCV7 serotypes 1, 3, 5, 6A, 7F, and 19A in Kuwait during 2010-2019
by: Eiman Mokaddas, et al.
Published: (2021)

PCV15, a pneumococcal conjugate vaccine, for the prevention of invasive pneumococcal disease in infants and children
by: Timothy J Chapman, et al.
Published: (2024)

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
by: Paolo Castiglia, et al.
Published: (2017)

Impact of PCV13 vaccination in Blantyre, Malawi
by: Portia Kamthunzi
Published: (2021)

Estimates on state-specific Pneumococcal Conjugate Vaccines (PCV) coverage in the private sector in the year 2012: Evidence from PCV utilization data
by: Habib Hasan Farooqui, et al.
Published: (2016)

Neonatal pneumococcal meningitis
by: FZ Mouad, et al.
Published: (2020)

Corticosteroids in Pneumococcal Meningitis
by: J Gordon Millichap
Published: (1991)

Invasive Pneumococcal Disease in Latvia in PCV10 Vaccination Era, 2012-2018
by: Larisa Savrasova, et al.
Published: (2021)

Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population
by: Derek Lytle, et al.
Published: (2023)

Impact of PCV10 on pediatric pneumococcal disease burden in Brazil: time for new recommendations?
by: Daniel Jarovsky, et al.
Published: (2023)

Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children
by: Josiah Ryman, et al.
Published: (2024)

Closing the pneumococcal conjugate vaccine (PCV) introduction gap: an archetype analysis of last-mile countries
by: Preetika Banerjee, et al.
Published: (2023)

Pneumococcal Meningitis in an Adolescent with Fever and Foot Ache
by: Catarina Dias, et al.
Published: (2013)

Response to PCV13 vaccination in patients with multiple myeloma versus healthy controls
by: S. Shahzad Mustafa, et al.
Published: (2019)

Abscess of Cavum Septum Pellucidum Complicating Pneumococcal Meningitis
by: J Gordon Millichap
Published: (2003)

Tingkat Pengetahuan Orang Tua terhadap Penyakit Pneumonia dan Imunisasi Pneumococcal Conjugate Vaccine (PCV) di Indonesia
by: Erlika Saputri, et al.
Published: (2020)

Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014
by: Michal Chowers, et al.
Published: (2017)

The economic impact of the switch from single- to multi-dose PCV13 vial in Benin
by: Patrick G. Ilboudo, et al.
Published: (2022)

Introduction of multi-dose PCV 13 vaccine in Benin: from the decision to vaccinators experience
by: Daleb Abdoulaye Alfa, et al.
Published: (2020)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Pneumococcal meningitis: epidemiological profile pre‐ and post‐introduction of the pneumococcal 10‐valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
by: Tatiane E. Hirose, et al.
Published: (2015)

A dose ranging study of 2 different formulations of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants
by: R. Rupp, et al.
Published: (2019)

Changes in invasive pneumococcal disease serotypes in a regional area of Australia following three years of 7vPCV introduction
by: Fakhrul Islam, et al.
Published: (2012)

Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis
by: Shabir A. Madhi
Published: (2015)

Recurrent pneumococcal meningitis in a splenectomised HIV-infected patient
by: Quesne Gilles, et al.
Published: (2003)

SEROTYPE CHARACTERISTIC OF PNEUMOCOCCI ISOLATED FROM PATIENTS WITH PNEUMOCOCCAL MENINGITIS
by: I. S. Koroleva, et al.
Published: (2012)

Pneumococcal conjugate vaccine and changing epidemiology of childhood bacterial meningitis
by: Shabir A. Madhi
Published: (2015)

Pneumococcal meningitis trends after pneumococcal conjugate vaccine introduction in Colombia: An interrupted time-series analysis
by: Diana C. Caceres, et al.
Published: (2018)